SCHEMBL4666587

SCHEMBL4666587

Cc1cccnc1-n1nc(C2CC2)cc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.49
▸ LMNA P02545 1/20 0.49
▸ TP53 P04637 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ SMN1; SMN2 Q16637 1/20 0.49
▸ HRH3 Q9Y5N1 1/20 0.39
▸ NOS3 P29474 1/20 0.38
▸ NOS1 P29475 1/20 0.38
▸ NOS2 P35228 1/20 0.38
▸ CRACR2A Q9BSW2 3/20 0.37
▸ OPRL1 P41146 3/20 0.36
▸ HTR3A P46098 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HTR7 P34969 1/20 0.35
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ KCNJ6 P48051 1/20 0.33
▸ KCNJ3 P48549 1/20 0.33
▸ NPY5R Q15761 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4665662 0.74 NOS3 (0.40) NPC1PKMRAB9ASMN1; SMN2HRH3
SCHEMBL3868458 0.73 NPC1 (0.65) NPC1LMNATP53PKMRAB9A
SCHEMBL15209785 0.72 SLC9A1 (0.49) NPC1LMNATP53PKMRAB9A
SCHEMBL2557636 0.72 NPC1 (0.63) NPC1LMNATP53PKMRAB9A
SCHEMBL1011586 0.71 RAB9A (0.88) NPC1LMNATP53PKMRAB9A
Hydrochloric Acid SCHEMBL3168718 0.71 NPC1 (0.61) NPC1LMNATP53PKMRAB9A
SCHEMBL18038915 0.70 RAB9A (0.65) NPC1LMNATP53PKMRAB9A
SCHEMBL4668551 0.69 SMN1; SMN2 (0.46) NPC1LMNATP53RAB9ASMN1; SMN2
SCHEMBL16648683 0.68 LCAT (0.45) LMNASMN1; SMN2ALDH1A1MAPT
SCHEMBL2027110 0.68 SMN1; SMN2 (0.60) NPC1LMNATP53PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 — — EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 — — WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 — — WO disclosed
Send feedback